NCT06235125 - Safety and Feasibility of Intraoperative Visualization With Cytalux in Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

January 20, 2026

Study Completion Date

January 20, 2026

Conditions

OsteosarcomaPulmonary MetastasisFluorescenceMetastatic SarcomaPediatrics

Interventions

DRUG

Cytalux

Folate analog ligand conjugated with an indole cyanine-like green dye as a solution in vials containing 3 mL at 2 mg/mL

Trial Locations (1)

RECRUITING

Ann & Robert H. Lurie Children's Hospital, Chicago